Category Archives: Jewel in the rough?

Don’t feel like chicken? ($NVAX)

Posted on November 12, 2011 by BioChef in Training

We wrap up an interesting week with thanks to all the veterans for their dedication and service. No where better to live than here in the US. And an interesting week it has been. While earnings continue to be reported, … Continue reading →

Posted in Jewel in the rough?, Research | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

$CYTR: $INNO and out with chaperones

Posted on May 17, 2011 by BioChef in Training

It has been an interesting couple of years for $CYTR. Their lead asset heading into 2008 was arimoclomol, a small molecule thought to activate Hsp70, which was placed on clinical hold (January 2008) over potential toxicology concerns in rats. While … Continue reading →

Posted in Jewel in the rough? | Tagged , , , , , | 1 Comment

$ICGN, “I can use more time”

Posted on May 3, 2011 by BioChef in Training

Nifty. I was thinking about posting this later this week after $ICGN’s 1Q11 results tomorrow, but then they go ahead and announce a research deal with Yale and $PFE to study the role of Nav1.7 in inherited erythrinelalgia (IEM) – … Continue reading →

Posted in Jewel in the rough? | Tagged , , , | 1 Comment